Coronary disease & ACS

Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical Implications

J Am Coll CardiolPublished Pooled analysis of individual patient data from randomised clinical trials

Pooled result · MI and repeat revascularizationResult — go to the resultOdds ratio 3.94 95% CI 1.79–8.67

Authors' conclusion

Graft failure is more frequent in women and is associated with adverse cardiac events. The excess mortality risk associated with female sex among CABG patients is not mediated by graft failure.

Study context

Population
CABG patients in RCTs with systematic imaging follow-up
Participants
4,413 patients7 RCTs
Comparison
Women vs men after CABG
  • Womenn = 777
Outcome
Association of graft failure with MI and repeat revascularization between CABG and imaging
Methodological detailssystematic imaging follow-up, mediation analysis
  • Systematic imaging follow-up
  • Mediation analysis

Pooled result

MI and repeat revascularization · median imaging follow-up 1.03 years

Odds ratio

3.94

95% CI 1.79–8.67

By group

Women

Graft failure, patient level
37.3%
Graft failure, graft level
20.5%

Men

Graft failure, patient level
32.9%
Graft failure, graft level
15.8%

Graft failure, patient level

Women37.3%
Men32.9%

Graft failure, graft level

Women20.5%
Men15.8%
Graft failurevs No graft failure
OR 3.94 (95% CI 1.79–8.67)

As reported in the abstract

Further pooled results

OutcomeEstimate
Death after imaging, in womenGraft failurevs No graft failureOR 3.18 (95% CI 1.73–5.85)
Death: female sex, mediation by graft failureWomenvs MenDirect effectHR 1.84 (95% CI 1.35–2.50)
Death: female sex, mediation by graft failureWomenvs MenIndirect effect via graft failureHR 1.04 (95% CI 0.86–1.26)

Original publication

Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical Implications. J Am Coll Cardiol. Published 9 July 2024. doi:10.1016/j.jacc.2024.04.046

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.